---
figid: PMC5297719__ijms-18-00085-g001
figtitle: 'Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic
  Breast Cancer: Trick or Treat?'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC5297719
filename: ijms-18-00085-g001.jpg
figlink: /pmc/articles/PMC5297719/figure/ijms-18-00085-f001/
number: F1
caption: 'The crosstalking network of signaling pathways involved in breast cancer
  development and progression: estrogen receptor (ER) signaling pathway, receptor
  tyrosine kinase (RTK) pathway, PIK3/AKT/mTOR pathway, MAPK signaling pathway, angiogenic
  pathway, SRC pathway and JAK/STAT pathway. ER: estrogen receptor, RAS: rat sarcoma
  viral oncogene homolog, B-RAF: murine sarcoma viral oncogene homolog, MEK1/2: MAPK/Erk
  kinase 1/2, ERK1/2: extracellular-signal-regulated kinase 1/2, SRC: rous sarcoma,
  RTKs: receptor tyrosine kinases, JAK: Janus kinase, STAT: Signal Transducer and
  Activator of Transcription, PI3K: Phosphoinositide 3-kinase, PTEN: Phosphatase and
  tensin homolog, AKT: protein kinase B, NFκB: nuclear factor κ-light-chain-enhancer
  of activated B cells, GSK3A/B: Glycogen synthase kinase-3 α/β, mTORC1/2: mammalian
  target of rapamycin complex 1/2, PIP: phosphatidylinositol phosphate, P: phosphorylated.
  Solid arrow: activation. Dashed arrow: activation of nuclear transcription factors.
  T-bar: inhibition.'
papertitle: 'Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic
  Breast Cancer: Trick or Treat?.'
reftext: Angela Toss, et al. Int J Mol Sci. 2017 Jan;18(1):85.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9714459
figid_alias: PMC5297719__F1
figtype: Figure
redirect_from: /figures/PMC5297719__F1
ndex: d21a4822-dec6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5297719__ijms-18-00085-g001.html
  '@type': Dataset
  description: 'The crosstalking network of signaling pathways involved in breast
    cancer development and progression: estrogen receptor (ER) signaling pathway,
    receptor tyrosine kinase (RTK) pathway, PIK3/AKT/mTOR pathway, MAPK signaling
    pathway, angiogenic pathway, SRC pathway and JAK/STAT pathway. ER: estrogen receptor,
    RAS: rat sarcoma viral oncogene homolog, B-RAF: murine sarcoma viral oncogene
    homolog, MEK1/2: MAPK/Erk kinase 1/2, ERK1/2: extracellular-signal-regulated kinase
    1/2, SRC: rous sarcoma, RTKs: receptor tyrosine kinases, JAK: Janus kinase, STAT:
    Signal Transducer and Activator of Transcription, PI3K: Phosphoinositide 3-kinase,
    PTEN: Phosphatase and tensin homolog, AKT: protein kinase B, NFκB: nuclear factor
    κ-light-chain-enhancer of activated B cells, GSK3A/B: Glycogen synthase kinase-3
    α/β, mTORC1/2: mammalian target of rapamycin complex 1/2, PIP: phosphatidylinositol
    phosphate, P: phosphorylated. Solid arrow: activation. Dashed arrow: activation
    of nuclear transcription factors. T-bar: inhibition.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - IGF1R
  - KDR
  - FLT1
  - FLT4
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - SRC
  - FGR
  - FYN
  - YES1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - KRAS
  - HRAS
  - NRAS
  - PTEN
  - BRAF
  - AKT1
  - AKT2
  - AKT3
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - RPTOR
  - MAP2K1
  - MAP2K2
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - GSK3B
  - GSK3A
  - MAPK3
  - MAPK1
  - Glucose
  - Cancer
  - Lung cancer
---
